NASDAQ
3.51USD
+0.01 (+0.29%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
91M
P/E
—
EPS
—
Beta
0.50
52W range
3.005-12.99
Day range
3.49–3.94
Open
3.78
Prev close
3.50
Volume
137.8K
Avg volume
82.6K
Dividend
0.00
IPO
2025-03-26
https://www.newsfilecorp.com/release/309173/NTHI-Brain-Cancer-Phase-2-Data-Expected-to-Spark-Triple-Confluence · 8/11/2026+0.60
https://www.globenewswire.com/news-release/2026/06/24/3316856/0/en/NeOnc-Ignites-Explosive-Summer-4-New-Research-Reports-UAE-Dubai-Drug-Approval-Fuel-Breakout-Momentum.html · 6/24/2026+0.90
https://www.newsfilecorp.com/release/302323/WSTPR-Catalyst-Watch-Abu-Dhabi-Regulatory-Clearance-Adds-Momentum-to-NeOncs-Global-NeuroOncology-Strategy · 6/22/2026+0.80
https://www.globenewswire.com/news-release/2026/06/16/3312943/0/en/Brain-Cancer-Innovator-NeOnc-Heads-into-Critical-Data-Season-with-Fresh-Abu-Dhabi-IND.html · 6/16/2026+0.80
https://www.newsfilecorp.com/release/301455/WSTPR-Catalyst-Watch-NeOnc-Strengthens-Capital-Position-Ahead-of-Potentially-Transformational-NeuroOncology-Updates · 6/15/2026+0.80
https://www.newsfilecorp.com/release/300674/The-Race-to-Defeat-Brain-Cancer-Could-Become-One-of-the-Biggest-Biotech-Stories-of-the-Decade · 6/9/2026+0.80
https://www.globenewswire.com/news-release/2026/03/13/3255499/0/en/NeOnc-Technologies-Appoints-David-Choi-as-Chief-Accounting-Officer.html · 3/13/2026+0.20
https://www.defenseworld.net/2026/01/10/neonc-technologies-nasdaqnthi-trading-up-1-7-heres-what-happened.html · 1/10/2026+0.20
https://www.globenewswire.com/news-release/2025/12/01/3197066/0/en/NeOnc-Technologies-Nasdaq-NTHI-Announces-AI-Driven-Findings-Showing-Ultrasound-Enhances-the-Potency-of-an-Already-Effective-NEO100-in-Treating-Primary-and-Metastatic-Brain-Tumors.html · 12/1/2025+0.90
https://www.globenewswire.com/news-release/2025/09/10/3147781/0/en/NeOnc-Technologies-Receives-FDA-Authorization-to-Proceed-with-Phase-II-Clinical-Trial-of-NEO212-A-First-in-Class-Oral-Chemical-Conjugated-Chemotherapy-Candidate-for-Brain-Cancer.html · 9/10/2025+0.80
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
